This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $781,760
Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics
CIHR · 2012 · Nominated PI
- $100,000
Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics
CIHR · 2012 · Nominated PI
Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics
Principal investigators: Tsui, Florence W
Keywords: Ankylosing Spondylitis; Diagnostic/Prognostic Markers; Pathogenesis; Therapeutics
Novel Biomarkers in ankylosing spondylitis: Implications for pathogenesis and therapeutics
Principal investigators: Tsui, Florence W
Keywords: Ankylosing Spondylitis; Diagnostic/Prognostic Markers; Pathogenesis; Therapeutics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.